Lomnytska M

ORCID: 0000-0003-2773-8446 · 3 papers in corpus
diagnostic-accuracy 2022
Cancers ·doi:10.3390/cancers14071757

BACKGROUND: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30-50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers…

diagnostic-accuracy 2018
Biomarker research ·doi:10.1186/s40364-018-0118-y

BACKGROUND: Platelets support cancer growth and spread making platelet proteins candidates in the search for biomarkers. METHODS: Two-dimensional (2D) gel electrophoresis, Partial Least Squares Discriminant Analysis (PLS-DA), Western blot,…

lab-animal 2012
British journal of cancer ·doi:10.1038/bjc.2012.67

BACKGROUND: Genomic stability is one of the crucial prognostic factors for patients with endometrioid endometrial cancer (EEC). The impact of genomic stability on the tumour tissue proteome of EEC is not yet well established. METHODS: Tiss…